Dr. Elda A. Flores-Contreras holds a BS in Genomic Biotechnology and a MSc and PhD in Molecular Biology and Genetic Engineering, all from the Universidad Autónoma de Nuevo León (UANL), Mexico. Her professional expertise focuses on molecular diagnostics, particularly through the application of microfluidic platforms and lab-on-a-chip technologies. She has participated in research including the design of an automated on-chip ELISA for the detection of anti-SARS-CoV-2 antibodies and the development of an isothermal amplification assay for the detection of high-risk HPV genotypes 16 and 18. Additionally, she has explored the role of long non-coding RNAs in cancer biology, including their involvement in the regulation of cell death and chemotherapy sensitivity.